CDC-RFA-CE21-2104: Preventing Violence Affecting Young Lives (PREVAYL)
Closed
This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control - NCIPC notices from 2021.
Centers for Disease Control - NCIPC offered grants of up to $250,000 (at least $225,000) to any type of organization. It expected to make about 8 awards worth $10.0 million in total. Applications closed on May 1, 2021.
From the official notice on Grants.gov, last changed April 21, 2021. Checked November 7, 2026.
- Award ceiling$250,000
- Award floor$225,000
- Total funding$10.0 million
- Expected awards8
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | March 2, 2021 |
|---|---|
| Deadline | May 1, 2021 |
Who can apply
This opportunity was open to any type of organization.
All 14 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Applicants must demonstrate a strong understanding of the public health approach to violence prevention and have experience implementing adolescents and young adult violence prevention strategies. Eligible applications must include the following to be responsive and move forward for review: Letter of support (LOS) or Memorandum of Understanding (MOU) from the applicant's local health department. Current/active violence prevention plan (the quality of the plan will be assessed via the evaluation criteria). Applicants must submit the MOU, MOA, LOS, and violence prevention plan as appropriate, name the file MOUs/MOAs/LOS/VPP, and upload it as a PDF file at www.grants.gov. Applications that do not meet the above criteria will be considered non-responsive and will not move forward for review.
Is this a realistic fit?
- Past Injury Prevention and Control Research and State and Community Based Programs awards averaged $2.2 million; this notice allows up to $250,000 per award.
- Most of the program's money (76% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The purpose of this funding is to address multiple forms of violence impacting adolescents and young adults, particularly in communities with high rates of violence, by implementing prevention approaches with an emphasis on the outer levels of the social-ecological model (i.e., community/societal levels). PREVAYL requires recipients to implement community/societal level strategies and approaches that address multiple forms of violence impacting adolescents and young adults, develop and/or enhance a jurisdictional violence prevention strategic plan, develop and implement an evaluation plan, develop a sustainability plan, and participate in a multi-sector coalition. In addition, this funding will address risk factors such as social determinants of health (e.g., concentrated poverty, limited educational/employment opportunities) and racial inequity (e.g., structural, systemic, and institutional racism).
Who has won Injury Prevention and Control Research and State and Community Based Programs grants before
From fiscal 2021 to 2025, Injury Prevention and Control Research and State and Community Based Programs (93.136) awarded $2.2 billion across 986 grant awards, an average of $2.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Florida Department of Health | Florida | 12 | $81.1 million |
| California Department of Public Health | California | 11 | $55.4 million |
| Ohio Department of Health | Ohio | 9 | $42.0 million |
| North Carolina Department of Health & Human Services | North Carolina | 12 | $42.0 million |
| Michigan Department of Health and Human Services | Michigan | 10 | $37.9 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-CE21-2104 still open?
No. It closed on May 1, 2021. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.
Who can apply for Preventing Violence Affecting Young Lives (PREVAYL)?
Centers for Disease Control - NCIPC accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Preventing Violence Affecting Young Lives (PREVAYL)?
Closed May 1, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $250,000 each. About $10.0 million in total across about 8 awards.
Who has won Injury Prevention and Control Research and State and Community Based Programs grants before?
The largest recipients over five fiscal years were Florida Department of Health, California Department of Public Health, Ohio Department of Health. The program made 986 awards worth $2.2 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)